S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Vitrolife AB (publ) Stock Price, News & Analysis (OTCMKTS:VTRLY)

$13.30
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
$13.30
▼
$13.30
50-Day Range
$11.45
▼
$13.30
52-Week Range
$11.45
▼
$21.49
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest

VTRLY stock logo

About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

VTRLY Stock Price History

VTRLY Stock News Headlines

October 27, 2023 | finance.yahoo.com
Vitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.
October 18, 2023 | wsj.com
Vitrolife AB
December 4, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
October 5, 2023 | finance.yahoo.com
Election committee for Vitrolife AB (publ)
October 4, 2023 | finance.yahoo.com
Vitrolife Group Annual and Sustainability Report 2022
October 4, 2023 | finance.yahoo.com
Vitrolife: Conference call interim report
October 4, 2023 | finance.yahoo.com
Vitrolife AB: Interim report Q1, 2023: Good start to the year
October 4, 2023 | finance.yahoo.com
Report from Annual General Meeting of Vitrolife AB (publ)
December 4, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
October 4, 2023 | finance.yahoo.com
Conference call interim report: Vitrolife AB (publ)
October 4, 2023 | finance.yahoo.com
Interim report Q2, 2023: Strong growth in APAC - Vitrolife AB (publ)
October 4, 2023 | finance.yahoo.com
Vitrolife AB (publ) announces changes in the Board of Directors
October 4, 2023 | finance.yahoo.com
Maria Forss, SVP Consumables business area, to leave the Vitrolife Group
October 4, 2023 | finance.yahoo.com
CEO has purchased shares in Vitrolife AB
See More Headlines
Receive VTRLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VTRLY
CUSIP
N/A
CIK
N/A
Web
www.vitrolife.com
Phone
46-3-17-21-80-00
Fax
N/A
Employees
1,109
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Bronwyn Brophy
    Chief Executive Officer
  • Mr. Patrik Tolf (Age 53)
    Chief Financial Officer
  • Mr. Claus Bisgaard (Age 46)
    Senior Vice President of Technologies
  • Mr. Rickard Ericsson (Age 52)
    Senior Vice President of Global Sales & Marketing
  • Guillermo Ferrando (Age 32)
    Vice President Strategy & Corporate development
  • Ms. Karin Koritz Russberg (Age 54)
    Senior Vice President of HR & Sustainability
  • Ricardo Capella (Age 55)
    Senior Vice President Genetic Services

Key Competitors

View All Competitors














VTRLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Vitrolife AB (publ) stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitrolife AB (publ) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VTRLY shares.
View VTRLY analyst ratings or view top-rated stocks.

How have VTRLY shares performed in 2023?

Vitrolife AB (publ)'s stock was trading at $11.93 at the beginning of 2023. Since then, VTRLY stock has increased by 11.5% and is now trading at $13.30.
View the best growth stocks for 2023 here.

How do I buy shares of Vitrolife AB (publ)?

Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:VTRLY) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -